HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA

Clinical Neurochemistry

Clinical Neurochemistry

Clinical neurochemistry, a specialized field within neuroscience, delves deeply into the intricate chemical processes and neurotransmitter systems operating within the nervous system. This branch focuses keenly on elucidating the mechanisms underlying neurological and psychiatric disorders. At its core, neurotransmitters serve as the pivotal messengers transmitting signals among neurons in the brain, exerting profound influence over a myriad of physiological and psychological functions. Serotonin, dopamine, norepinephrine, glutamate, and gamma-aminobutyric acid (GABA) stand as quintessential neurotransmitters, governing aspects ranging from mood regulation and cognition to behavior and emotion. Within the realm of clinical neurochemistry, experts meticulously investigate the synthesis, release, reuptake, and metabolism of these neurotransmitters. By discerning alterations within these systems, researchers gain crucial insights into the pathophysiology of various disorders. Conditions such as depression, anxiety, schizophrenia, bipolar disorder, Parkinson's disease, Alzheimer's disease, and substance use disorders all fall under the purview of clinical neurochemists' scrutiny. Employing a diverse array of research methodologies, including biochemical assays, neuroimaging techniques like PET and SPECT scans, pharmacological studies, and genetic analyses, these scientists meticulously unravel the neurochemical intricacies underpinning these ailments. Through such multifaceted approaches, they endeavor to uncover the subtle yet profound ways in which neurotransmitter dysregulation contributes to disease manifestation. However, the ultimate goal extends far beyond mere comprehension; clinical neurochemists aspire to leverage this knowledge to pioneer novel pharmacological treatments and interventions. By targeting specific neurochemical pathways, they aim to alleviate symptoms, enhance quality of life, and nurture brain health. This pursuit of innovative therapeutics underscores the transformative potential inherent in deciphering the neurochemical underpinnings of neurological and psychiatric disorders. In essence, clinical neurochemistry represents a dynamic field at the nexus of cutting-edge scientific inquiry and tangible clinical impact. Its practitioners, armed with an arsenal of sophisticated tools and methodologies, strive tirelessly to unravel the intricate tapestry of neurotransmitter dynamics. Through their relentless dedication, they illuminate the path towards novel therapeutic avenues, holding promise for countless individuals grappling with the burdens of neurological and psychiatric afflictions.

Committee Members
Speaker at Neuroscience Conference - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia
Speaker at Neurology and Brain Disorders - Joe Sam Robinson

Joe Sam Robinson

Mercer University, United States
Speaker at Neurology Conferences - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
INBC 2025 Speakers
Speaker at Brain Disorders Conference - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Neuroscience Conference - Roger H Coletti

Roger H Coletti

Interventional Health, PA, United States
Speaker at Neuroscience Conference - Stephen Grossberg

Stephen Grossberg

Boston University, United States
Speaker at Brain Disorders Conference - George Diaz

George Diaz

Memorial Healthcare Systems, United States
Tags

Submit your abstract Today

Watsapp